medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2022, Number 1

<< Back Next >>

Acta Ortop Mex 2022; 36 (1)

Validation of the modified IMPROVE scale in patients undergoing primary total hip arthroplasty

Ríos-Zavala E, Araiza-Nava B, Morales-López A, Jiménez-Capetillo J, Esquivel-Gómez R, Reyes-Meza G

Language: Spanish
References: 14
Page: 26-32
PDF size: 219.24 Kb.


ABSTRACT

Introduction: Major orthopedic surgery such as total hip arthroplasty (THA) is associated with an increased risk of postoperative complications. Candidates for THA are often older adults, with comorbidities that increase the risk of major bleeding, the IMPROVE scale has independent actors on the risk of bleeding according to the characteristics of the patients at hospital admission. It foresees the possibility of hemorrhage and the need for blood transfusion, being support in decision-making in the planning of a safe THA with the provision of the necessary resources. Objective: To evaluate the sensitivity, validity and reliability of the modified IMPROVE scale in patients undergoing primary total hip arthroplasty. Material and methods: Study of processes with a sample of 131 patients undergoing primary THA, in the period from January 01, 2018 to July 01, 2018. Results: The scale presents good reliability, as for the performance of the scale, a good sensitivity was obtained, classifying 96.9% of the patients correctly; which is suitable for the type of scale. Conclusions: The modified IMPROVE scale is a discretely adequate and useful tool for the prognosis of bleeding risk in patients who undergo THA, compared with other assessment scales developed in other geographical areas. It is recommended to continue with the study of risk factors for major bleeding in this specific population.


REFERENCES

  1. Quintero JI, Cardenas LL, Navas M, Bautista MP, Bonilla GA, Llinas AM. Primary joint arthroplasty surgery: is the risk of major bleeding higher in elderly patients? A retrospective cohort study. J Arthroplasty. 2016; 31(10): 2264-8.

  2. Oberweis BS, Nukala S, Rosenberg A, Guo Y, Stuchin S, Radford MJ, et al. Thrombotic and bleeding complications after orthopedic surgery. Am Heart J. 2013; 165(3): 427-33.e1.

  3. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6 Suppl): 257S-98S.

  4. Spyropoulos AC, Anderson FA, FitzGerald G, Decousus H, Pini M, Chong BH, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011; 140(3): 706-14.

  5. Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK, et al. Factors at admission associated with bleeding risk in medical patients: findings from the improve investigators. Chest. 2011; 139(1): 69-79.

  6. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010; 138(5): 1093-100.

  7. Cajigas Melgoza JC, Ariza Andraca R, Espinosa Morales R, Méndez Medina C, Mirassou Ortega M, Robles San Román M, et al. Guía de práctica clínica basada en la evidencia para el diagnóstico y tratamiento de la osteoartritis. Med Int Mex. 2011; 27(6): 552-72.

  8. Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015; 10: 48.

  9. Wasung ME, Chawla LS, Madero M. Biomarkers of renal function, which and when? Clin Chim Acta. 2015; 438: 350-7.

  10. Krstic D, Tomic N, Radosavljevic B, Avramovic N, Dragutinovic V, Skodric SR, et al. Biochemical markers of renal function. Curr Med Chem. 2016; 23(19): 2018-40.

  11. IMPROVE. IMPROVE Risk Score Online Calculator [Internet]. Available in: https://www.outcomes-umassmed.org/IMPROVE/risk_score/index.html

  12. Hostler DC, Marx ES, Moores LK, Petteys SK, Hostler JM, Mitchell JD, et al. Validation of the international medical prevention registry on venous thromboembolism bleeding risk score. Chest. 2016; 149(2): 372-9.

  13. Hochreiter J, Hejkrlik W, Emmanuel K, Hitzl W, Ortmaier R. Blood loss and transfusion rate in short stem hip arthroplasty. A comparative study. Int Orthop. 2017; 41(7): 1347-53.

  14. Zulkifly H, Lip GYH, Lane DA. Bleeding risk scores in atrial fibrillation and venous thromboembolism. Am J Cardiol. 2017; 120(7): 1139-45.



EVIDENCE LEVEL

III




2020     |     www.medigraphic.com